États-Unis - anglais - NLM (National Library of Medicine)

a-s medication solutions - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tubersol tuberculin purified protein derivative (mantoux), is indicated to aid diagnosis of tuberculosis infection (tb) in persons at increased risk of developing active disease. the centers for disease control and prevention (cdc) have published guidelines regarding populations that would benefit from tuberculin skin testing (tst). current recommendations can be accessed at: http://www.cdc.gov/tb/publications/factsheets/testing.htm. previous bcg vaccination is not a contraindication to tuberculin testing. the skin-test results of bcg vaccinated persons can be used to support or exclude the diagnosis of tb infection. however, an fda-approved interferon gamma release assay is preferred over tuberculin skin test for persons 5 years of age and older who were previously vaccinated with bcg. (8) allergy to any component of tubersol or an anaphylactic or other allergic reaction to a previous test of tuberculin ppd is a contraindication to the use of tubersol. (see description and how supplied.) tubersol should not

États-Unis - anglais - NLM (National Library of Medicine)

par pharmaceutical, inc. - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tuberculin ppd is indicated as an aid in the detection of infection with mycobacterium tuberculosis . the standard tuberculin test employs the intradermal (mantoux) test using a 5 tu dose of tuberculin ppd.7 the 0.1 ml test dose of aplisol (tuberculin ppd, diluted) is equivalent to the 5 tu dose which has been clinically utilized and standardized with ppd-s. tuberculin skin testing is not contraindicated for persons who have been vaccinated with bcg and the skin-test results of such persons are used to support or exclude the diagnosis of m. tuberculosis infections.4 hiv infection is a strong risk factor for the development of tb disease in persons having tb infection. all hiv-infected persons should receive a ppd-tuberculin skin test.3 aplisol is contraindicated in patients with known hypersensitivity or allergy to aplisol or any of its components. aplisol should not be administered to persons who have previously experienced a severe reaction (e.g., vesiculation, ulceration, or necrosis) because of the sev

États-Unis - anglais - NLM (National Library of Medicine)

natural health supply - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 30 [hp_c] - indications: to be used for acute, self-limiting conditions according to standard homeopathic indications.

États-Unis - anglais - NLM (National Library of Medicine)

seroyal usa - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 24 [hp_x] - indications promotes overall health and well being indications promotes overall health and well being directions adults: take five granules three times daily or as recommended by your healthcare practitioner. children: take three granules and follow adult directions.

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ir/ml (dermatophagoides farinae body extract) - solution for injection - 10 ir/ml - active: allergen extracts 10 ir/ml (dermatophagoides farinae body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ir/ml (betula alba pollen extract) - solution for injection - 10 ir/ml - active: allergen extracts 10 ir/ml (betula alba pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ir/ml (feline epithelium extract) - solution for injection - 10 ir/ml - active: allergen extracts 10 ir/ml (feline epithelium extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ir/ml (canine epithelium extract) - solution for injection - 10 ir/ml - active: allergen extracts 10 ir/ml (canine epithelium extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) - solution for injection - 10 ir/ml - active: allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ic/ml (chenopodium album pollen extract) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (chenopodium album pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water